We mobilize the full power of the global medtech community to move the most promising medical device, diagnostic, and digital health innovations past the barriers between innovation and the patient.
Four advantages no other accelerator can offer at once, from the moment a company applies to the day it reaches the market.
Expert reviewers, live pitches, and a strategic selection committee surface the strongest companies from a deep applicant pool. By the time a company is in, the market has already vetted it.
The companies that partner with and acquire medtech startups help select and mentor every cohort. Founders hear directly from the people they’re building toward, long before a deal is on the table.
A first-in-human study and a commercial launch need different things. Programming adapts to each company’s stage, so the support fits the moment instead of a fixed curriculum.
A live benchmark tracking growth, survival, and commercial traction across the portfolio.
Building medtech is uniquely hard. The regulatory path is long, the capital needs are steep, and the buyers are the most demanding in any industry. We help you through all of it, and connect you with the partners who can bring your technology to patients at scale.
Building a medtech company is uniquely hard. The regulatory landscape is complex, the go-to-market path is long, and the talent is different. We designed everything, our curriculum, our mentors, our network, around that reality.
We've reviewed thousands of applications. Our rigorous selection process ensures every company in our program has the fundamentals to succeed — strong IP, experienced team, and a credible path to market.
Our curriculum is built on what actually works in medtech. From 510(k) to PMA, from Series A to IPO — we teach the playbooks that top medtech companies have used to win.
Whether you're in Silicon Valley or São Paulo, our global network of mentors, partners, and investors is accessible to you. We've built the most concentrated medtech network in the world.
We measure ourselves by your outcomes. $12B raised, 93% still operating, 40+ acquisitions — these are the metrics that matter, and they're why the world's top medtech companies trust us with their pipeline.
Our team has built, funded, and scaled medtech companies. We speak your language and understand your challenges from day one.
Direct access to 289 member organizations including the largest medtech corporates, health systems, and investors worldwide.
Intensive programming designed for medtech: regulatory pathways, reimbursement strategy, sales cycles, and clinical evidence generation.
Warm introductions to the investors who back medtech, plus an annual showcase where $12B+ in deals have been done.
Our portfolio spans every major therapeutic area and geography — cardiac, neuro, ortho, diagnostics, digital health, and more. Companies in 40+ countries have moved medtech forward with us.
Whether you're a founder with a breakthrough device, a corporate looking to stay ahead of innovation, or an investor seeking deal flow — we've built a place for you.
Our accelerator programs have helped over 600 companies access the capital, partnerships, and expertise they need to grow.
Learn more →Members get first access to our deal flow — the most curated pipeline of emerging medtech anywhere. Early visibility, early advantage.
Become a member →Our partner network of 40+ strategic organizations helps portfolio companies accelerate clinical validation, manufacturing, and commercialization.
Meet our partners →We surface the top 1% of medtech companies before they raise. Investor members get proprietary access to our pipeline before Demo Day.
Invest →Our track record speaks for itself. Companies that go through our programs raise significantly more capital and do it faster.
See portfolio →From seed-stage spinouts to growth-stage platforms — our annual showcase surfaces the companies that are ready for your partnership.
Attend showcase →MedTech Innovator gave us access to mentors who had actually built medtech companies. They cut through the noise and helped us sharpen our 510(k) strategy. We closed our Series A six months after Demo Day. — Sarah Chen, CEO & Co-Founder
The corporate connections alone were worth it. We got introductions to three strategic partners through MTI that we wouldn't have found on our own. One turned into our first commercial partnership. — Marcus Rivera, Co-Founder & CTO
The MedTech Innovator network is genuinely different. These are people who've been in the trenches — they understand the regulatory path, the reimbursement game, and the hospital sales cycle. — Dr. Priya Patel, Founder & Chief Medical Officer
289 corporate, investor, and health system members. They come for the deal flow. They stay for the network.
Become a MemberThe MedTech Innovator showcase is where deals get done. 289 member organizations attend specifically to find their next investment, acquisition, or commercial partner.
Our selection process is rigorous — only the top 1% of applicants are accepted. Which means when a company presents at our showcase, investors and corporates know it's worth their attention.
Apply to ShowcaseA look back at the milestones, raises, exits, and breakthroughs from our portfolio last year.
Digital health, AI diagnostics, and minimally invasive surgery are dominating deal flow. Here's what investors are prioritizing.
FDA clearances, fundraising rounds, and clinical milestones from across our global portfolio this quarter.
Join 20,000+ medtech leaders getting our weekly briefing on the companies, capital, and trends shaping the future of healthcare.
